CareFusion (NYSE: CFN) is one of 80 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its rivals? We will compare CareFusion to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.

Institutional and Insider Ownership

65.7% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 12.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares CareFusion and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CareFusion N/A N/A 25.51
CareFusion Competitors $975.11 million $120.37 million 253.57

CareFusion’s rivals have higher revenue and earnings than CareFusion. CareFusion is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares CareFusion and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CareFusion 16.18% 12.80% 7.62%
CareFusion Competitors -426.09% -25.97% -11.38%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for CareFusion and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareFusion 0 0 0 0 N/A
CareFusion Competitors 273 1326 2802 100 2.61

As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.51%. Given CareFusion’s rivals higher possible upside, analysts plainly believe CareFusion has less favorable growth aspects than its rivals.

Summary

CareFusion rivals beat CareFusion on 5 of the 8 factors compared.

CareFusion Company Profile

CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company’s primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Receive News & Ratings for CareFusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareFusion and related companies with MarketBeat.com's FREE daily email newsletter.